tooluniverse-gwas-trait-to-gene

Discover genes associated with diseases and traits using GWAS data from the GWAS Catalog (500,000+ associations) and Open Targets Genetics (L2G predictions). Identifies genetic risk factors, prioritizes causal genes via locus-to-gene scoring, and assesses druggability. Use when asked to find genes associated with a disease or trait, discover genetic risk factors, translate GWAS signals to gene targets, or answer questions like "What genes are associated with type 2 diabetes?"

912 stars

Best use case

tooluniverse-gwas-trait-to-gene is best used when you need a repeatable AI agent workflow instead of a one-off prompt.

Discover genes associated with diseases and traits using GWAS data from the GWAS Catalog (500,000+ associations) and Open Targets Genetics (L2G predictions). Identifies genetic risk factors, prioritizes causal genes via locus-to-gene scoring, and assesses druggability. Use when asked to find genes associated with a disease or trait, discover genetic risk factors, translate GWAS signals to gene targets, or answer questions like "What genes are associated with type 2 diabetes?"

Teams using tooluniverse-gwas-trait-to-gene should expect a more consistent output, faster repeated execution, less prompt rewriting.

When to use this skill

  • You want a reusable workflow that can be run more than once with consistent structure.

When not to use this skill

  • You only need a quick one-off answer and do not need a reusable workflow.
  • You cannot install or maintain the underlying files, dependencies, or repository context.

Installation

Claude Code / Cursor / Codex

$curl -o ~/.claude/skills/tooluniverse-gwas-trait-to-gene/SKILL.md --create-dirs "https://raw.githubusercontent.com/wu-yc/LabClaw/main/skills/bio/tooluniverse-gwas-trait-to-gene/SKILL.md"

Manual Installation

  1. Download SKILL.md from GitHub
  2. Place it in .claude/skills/tooluniverse-gwas-trait-to-gene/SKILL.md inside your project
  3. Restart your AI agent — it will auto-discover the skill

How tooluniverse-gwas-trait-to-gene Compares

Feature / Agenttooluniverse-gwas-trait-to-geneStandard Approach
Platform SupportNot specifiedLimited / Varies
Context Awareness High Baseline
Installation ComplexityUnknownN/A

Frequently Asked Questions

What does this skill do?

Discover genes associated with diseases and traits using GWAS data from the GWAS Catalog (500,000+ associations) and Open Targets Genetics (L2G predictions). Identifies genetic risk factors, prioritizes causal genes via locus-to-gene scoring, and assesses druggability. Use when asked to find genes associated with a disease or trait, discover genetic risk factors, translate GWAS signals to gene targets, or answer questions like "What genes are associated with type 2 diabetes?"

Where can I find the source code?

You can find the source code on GitHub using the link provided at the top of the page.

SKILL.md Source

# GWAS Trait-to-Gene Discovery

**Discover genes associated with diseases and traits using genome-wide association studies (GWAS)**

## Overview

This skill enables systematic discovery of genes linked to diseases/traits by analyzing GWAS data from two major resources:
- **GWAS Catalog** (EBI/NHGRI): Curated catalog of published GWAS with >500,000 associations
- **Open Targets Genetics**: Fine-mapped GWAS signals with locus-to-gene (L2G) predictions

## Use Cases

**Clinical Research**
- "What genes are associated with type 2 diabetes?"
- "Find genetic risk factors for coronary artery disease"
- "Which genes contribute to Alzheimer's disease susceptibility?"

**Drug Target Discovery**
- Identify genes with strong genetic evidence for disease causation
- Prioritize targets based on L2G scores and replication across studies
- Find genes with genome-wide significant associations (p < 5e-8)

**Functional Genomics**
- Map disease-associated variants to candidate genes
- Analyze genetic architecture of complex traits
- Understand polygenic disease mechanisms

## Workflow

```
1. Trait Search → Search GWAS Catalog by disease/trait name
       ↓
2. SNP Aggregation → Collect genome-wide significant SNPs (p < 5e-8)
       ↓
3. Gene Mapping → Extract mapped genes from associations
       ↓
4. Evidence Ranking → Score by p-value, replication, fine-mapping
       ↓
5. Annotation (Optional) → Add L2G predictions from Open Targets
```

## Key Concepts

**Genome-wide Significance**
- Standard threshold: p < 5×10⁻⁸
- Accounts for multiple testing burden across ~1M common variants
- Higher confidence: p < 5×10⁻¹⁰ or replicated across studies

**Gene Mapping Methods**
- **Positional**: Nearest gene to lead SNP
- **Fine-mapping**: Statistical refinement to credible variants
- **Locus-to-Gene (L2G)**: Integrative score combining multiple evidence types

**Evidence Confidence Levels**
- **High**: L2G score > 0.5 OR multiple studies with p < 5e-10
- **Medium**: 2+ studies with p < 5e-8
- **Low**: Single study or marginal significance

## Required ToolUniverse Tools

### GWAS Catalog (11 tools)
- `gwas_get_associations_for_trait` - Get all associations for a trait (sorted by p-value)
- `gwas_search_snps` - Search SNPs by gene mapping
- `gwas_get_snp_by_id` - Get SNP details (MAF, consequence, location)
- `gwas_get_study_by_id` - Get study metadata
- `gwas_search_associations` - Search associations with filters
- `gwas_search_studies` - Search studies by trait/cohort
- `gwas_get_associations_for_snp` - Get all associations for a SNP
- `gwas_get_variants_for_trait` - Get variants for a trait
- `gwas_get_studies_for_trait` - Get studies for a trait
- `gwas_get_snps_for_gene` - Get SNPs mapped to a gene
- `gwas_get_associations_for_study` - Get associations from a study

### Open Targets Genetics (6 tools)
- `OpenTargets_search_gwas_studies_by_disease` - Search studies by disease ontology
- `OpenTargets_get_study_credible_sets` - Get fine-mapped loci for a study
- `OpenTargets_get_variant_credible_sets` - Get credible sets for a variant
- `OpenTargets_get_variant_info` - Get variant annotation (frequencies, consequences)
- `OpenTargets_get_gwas_study` - Get study metadata
- `OpenTargets_get_credible_set_detail` - Get detailed credible set information

## Parameters

**Required**
- `trait` - Disease/trait name (e.g., "type 2 diabetes", "coronary artery disease")

**Optional**
- `p_value_threshold` - Significance threshold (default: 5e-8)
- `min_evidence_count` - Minimum number of studies (default: 1)
- `max_results` - Maximum genes to return (default: 100)
- `use_fine_mapping` - Include L2G predictions (default: true)
- `disease_ontology_id` - Disease ontology ID for Open Targets (e.g., "MONDO_0005148")

## Output Schema

```python
{
  "genes": [
    {
      "symbol": str,              # Gene symbol (e.g., "TCF7L2")
      "min_p_value": float,       # Most significant p-value
      "evidence_count": int,      # Number of independent studies
      "snps": [str],              # Associated SNP rs IDs
      "studies": [str],           # GWAS study accessions
      "l2g_score": float | null,  # Locus-to-gene score (0-1)
      "credible_sets": int,       # Number of credible sets
      "confidence_level": str     # "High", "Medium", or "Low"
    }
  ],
  "summary": {
    "trait": str,
    "total_associations": int,
    "significant_genes": int,
    "data_sources": ["GWAS Catalog", "Open Targets"]
  }
}
```

## Example Results

**Type 2 Diabetes**
```
TCF7L2:  p=1.2e-98, 15 studies, L2G=0.82 → High confidence
KCNJ11:  p=3.4e-67, 12 studies, L2G=0.76 → High confidence
PPARG:   p=2.1e-45, 8 studies,  L2G=0.71 → High confidence
FTO:     p=5.6e-42, 10 studies, L2G=0.68 → High confidence
IRS1:    p=8.9e-38, 6 studies,  L2G=0.54 → High confidence
```

**Alzheimer's Disease**
```
APOE:    p=1.0e-450, 25 studies, L2G=0.95 → High confidence
BIN1:    p=2.3e-89,  18 studies, L2G=0.88 → High confidence
CLU:     p=4.5e-67,  16 studies, L2G=0.82 → High confidence
ABCA7:   p=6.7e-54,  14 studies, L2G=0.79 → High confidence
CR1:     p=8.9e-52,  13 studies, L2G=0.75 → High confidence
```

## Best Practices

**1. Use Disease Ontology IDs for Precision**
```
# Instead of:
discover_gwas_genes("diabetes")  # Ambiguous

# Use:
discover_gwas_genes(
    "type 2 diabetes",
    disease_ontology_id="MONDO_0005148"  # Specific
)
```

**2. Filter by Evidence Strength**
```
# For drug targets, require strong evidence:
discover_gwas_genes(
    "coronary artery disease",
    p_value_threshold=5e-10,    # Stricter than GWAS threshold
    min_evidence_count=3,       # Multiple independent studies
    use_fine_mapping=True       # Include L2G predictions
)
```

**3. Interpret Results Carefully**
- **Association ≠ Causation**: GWAS identifies correlated variants, not necessarily causal genes
- **Linkage Disequilibrium**: Lead SNP may tag the true causal variant in a nearby gene
- **Fine-mapping**: L2G scores provide better causal gene evidence than positional mapping
- **Functional Evidence**: Validate with orthogonal data (eQTLs, knockout models, etc.)

## Limitations

1. **Gene Mapping Uncertainty**
   - Positional mapping assigns SNPs to nearest gene (may be incorrect)
   - Fine-mapping available for only a subset of studies
   - Intergenic variants difficult to map

2. **Population Bias**
   - Most GWAS in European populations
   - Effect sizes may differ across ancestries
   - Rare variants often under-represented

3. **Sample Size Dependence**
   - Larger studies detect more associations
   - Older small studies may have false negatives
   - p-values alone don't indicate effect size

4. **Validation Bug**
   - Some ToolUniverse tools have oneOf validation issues
   - Use `validate=False` parameter if needed
   - This is automatically handled in the Python implementation

## Related Skills

- **Variant-to-Disease Association**: Look up specific SNPs (e.g., rs7903146 → T2D)
- **Gene-to-Disease Links**: Find diseases associated with known genes
- **Drug Target Prioritization**: Rank targets by genetic evidence
- **Population Genetics Analysis**: Compare allele frequencies across populations

## Data Sources

**GWAS Catalog**
- Curator: EBI and NHGRI
- URL: https://www.ebi.ac.uk/gwas/
- Coverage: 100,000+ publications, 500,000+ associations
- Update Frequency: Weekly

**Open Targets Genetics**
- Curator: Open Targets consortium
- URL: https://genetics.opentargets.org/
- Coverage: Fine-mapped GWAS, L2G predictions, QTL colocalization
- Update Frequency: Quarterly

## Citation

If you use this skill in research, please cite:

```
Buniello A, et al. (2019) The NHGRI-EBI GWAS Catalog of published genome-wide
association studies. Nucleic Acids Research, 47(D1):D1005-D1012.

Mountjoy E, et al. (2021) An open approach to systematically prioritize causal
variants and genes at all published human GWAS trait-associated loci.
Nature Genetics, 53:1527-1533.
```

## Support

For issues with:
- **Skill functionality**: Open issue at tooluniverse/skills
- **GWAS data**: Contact GWAS Catalog or Open Targets support
- **Tool errors**: Check ToolUniverse tool status

Related Skills

tooluniverse-target-research

912
from wu-yc/LabClaw

Gather comprehensive biological target intelligence from 9 parallel research paths covering protein info, structure, interactions, pathways, expression, variants, drug interactions, and literature. Features collision-aware searches, evidence grading (T1-T4), explicit Open Targets coverage, and mandatory completeness auditing. Use when users ask about drug targets, proteins, genes, or need target validation, druggability assessment, or comprehensive target profiling.

tooluniverse-protein-therapeutic-design

912
from wu-yc/LabClaw

Design novel protein therapeutics (binders, enzymes, scaffolds) using AI-guided de novo design. Uses RFdiffusion for backbone generation, ProteinMPNN for sequence design, ESMFold/AlphaFold2 for validation. Use when asked to design protein binders, therapeutic proteins, or engineer protein function.

tooluniverse-pharmacovigilance

912
from wu-yc/LabClaw

Analyze drug safety signals from FDA adverse event reports, label warnings, and pharmacogenomic data. Calculates disproportionality measures (PRR, ROR), identifies serious adverse events, assesses pharmacogenomic risk variants. Use when asked about drug safety, adverse events, post-market surveillance, or risk-benefit assessment.

tooluniverse-network-pharmacology

912
from wu-yc/LabClaw

Construct and analyze compound-target-disease networks for drug repurposing, polypharmacology discovery, and systems pharmacology. Builds multi-layer networks from ChEMBL, OpenTargets, STRING, DrugBank, Reactome, FAERS, and 60+ other ToolUniverse tools. Calculates Network Pharmacology Scores (0-100), identifies repurposing candidates, predicts mechanisms, and analyzes polypharmacology. Use when users ask about drug repurposing via network analysis, multi-target drug effects, compound-target-disease networks, systems pharmacology, or polypharmacology.

tooluniverse-drug-target-validation

912
from wu-yc/LabClaw

Comprehensive computational validation of drug targets for early-stage drug discovery. Evaluates targets across 10 dimensions (disambiguation, disease association, druggability, chemical matter, clinical precedent, safety, pathway context, validation evidence, structural insights, validation roadmap) using 60+ ToolUniverse tools. Produces a quantitative Target Validation Score (0-100) with GO/NO-GO recommendation. Use when users ask about target validation, druggability assessment, target prioritization, or "is X a good drug target for Y?"

tooluniverse-drug-research

912
from wu-yc/LabClaw

Generates comprehensive drug research reports with compound disambiguation, evidence grading, and mandatory completeness sections. Covers identity, chemistry, pharmacology, targets, clinical trials, safety, pharmacogenomics, and ADMET properties. Use when users ask about drugs, medications, therapeutics, or need drug profiling, safety assessment, or clinical development research.

tooluniverse-drug-repurposing

912
from wu-yc/LabClaw

Identify drug repurposing candidates using ToolUniverse for target-based, compound-based, and disease-driven strategies. Searches existing drugs for new therapeutic indications by analyzing targets, bioactivity, safety profiles, and literature evidence. Use when exploring drug repurposing opportunities, finding new indications for approved drugs, or when users mention drug repositioning, off-label uses, or therapeutic alternatives.

tooluniverse-drug-drug-interaction

912
from wu-yc/LabClaw

Comprehensive drug-drug interaction (DDI) prediction and risk assessment. Analyzes interaction mechanisms (CYP450, transporters, pharmacodynamic), severity classification, clinical evidence grading, and provides management strategies. Supports single drug pairs, polypharmacy analysis (3+ drugs), and alternative drug recommendations. Use when users ask about drug interactions, medication safety, polypharmacy risks, or need DDI assessment for clinical decision support.

tooluniverse-chemical-safety

912
from wu-yc/LabClaw

Comprehensive chemical safety and toxicology assessment integrating ADMET-AI predictions, CTD toxicogenomics, FDA label safety data, DrugBank safety profiles, and STITCH chemical-protein interactions. Performs predictive toxicology (AMES, DILI, LD50, carcinogenicity), organ/system toxicity profiling, chemical-gene-disease relationship mapping, regulatory safety extraction, and environmental hazard assessment. Use when asked about chemical toxicity, drug safety profiling, ADMET properties, environmental health risks, chemical hazard assessment, or toxicogenomic analysis.

tooluniverse-chemical-compound-retrieval

912
from wu-yc/LabClaw

Retrieves chemical compound information from PubChem and ChEMBL with disambiguation, cross-referencing, and quality assessment. Creates comprehensive compound profiles with identifiers, properties, bioactivity, and drug information. Use when users need chemical data, drug information, or mention PubChem CID, ChEMBL ID, SMILES, InChI, or compound names.

tooluniverse-binder-discovery

912
from wu-yc/LabClaw

Discover novel small molecule binders for protein targets using structure-based and ligand-based approaches. Creates actionable reports with candidate compounds, ADMET profiles, and synthesis feasibility. Use when users ask to find small molecules for a target, identify novel binders, perform virtual screening, or need hit-to-lead compound identification.

tooluniverse-antibody-engineering

912
from wu-yc/LabClaw

Comprehensive antibody engineering and optimization for therapeutic development. Covers humanization, affinity maturation, developability assessment, and immunogenicity prediction. Use when asked to optimize antibodies, humanize sequences, or engineer therapeutic antibodies from lead to clinical candidate.